Hepatitis E virus infection: Epidemiology and treatment implications

Table 1 Global prevalence of anti-hepatitis E virus IgG in different populations

Regions	Prevalence (%)	Ref.
Low-to-medium income
Kashmir region	49.6	Khuroo et al[35]
India	23.8-28.7	Mathur et al[76]
Myanmar	32.0	Nakai et al[77]
Egypt	67.7	Stoszek et al[71]
Bangladesh	22.5	Labrique et al[78]
China	19.7	Dong et al[79]
Mexico	36.6	Alvarado-Esquivel et al[80]
Thailand	14.0	Gonwong et al[75]
Nigeria	42.7	Junaid et al[81]
Industrialized
Germany	17.0	Wenzel et al[82]
United States	6.0	Teshale et al[83]